What are the trends in the treatment of multiple sclerosis in recent studies? – A bibliometric analysis with global productivity during 1980–2021

医学 多发性硬化 格拉默 芬戈莫德 主题(文档) 生产力 文献计量学 家庭医学 图书馆学 精神科 计算机科学 宏观经济学 经济
作者
Serdar Aykaç,Sinan Eliaçık
出处
期刊:Multiple sclerosis and related disorders [Elsevier BV]
卷期号:68: 104185-104185 被引量:19
标识
DOI:10.1016/j.msard.2022.104185
摘要

There is no bibliometric analysis in the literature on the subject of the treatment of multiple sclerosis (MS), which is a disease with increasing prevalence, severely affecting the life and quality of life of patients. The purpose of this study was to analyze the scientific articles published on the subject of MS treatment, using bibliometric approaches and statistical methods, and thereby show the trend subjects and global productivity.From 14,443 publications on the subject of MS between 1980 and 2021, 5010 in the category of article were retrieved from the Web of Science and analyzed statistically. Bibliometric network visualization diagrams were created to determine trend subjects, collaborations between countries and citation analyzes. Exponential Smoothing estimation was used to predict the number of articles to be published in the next 5 years. Correlations were determined using Spearman's correlation analysis.The 3 countries contributing the most to literature were found to be the USA (1385, 37.6%), Italy (700, 13.9%), and Germany (694, 13.8%). The most productive author was Hartung Hans-Peter (n = 82) and the most productive institution was the University of London (n = 198). The three most productive journals were the Multiple Sclerosis Journal (n = 354), Multiple Sclerosis and Related Disorders (n = 224), and Neurology (n = 204). The most studied subjects can be listed from past to present as interferon beta, disease-modifying treatment or drugs, relapsing, natalizumab, fingolimod, glatiramer acetate, fatigue, alemtuzumab, cytokines, mitoxantrone, MRI, adherence, depression, experimental autoimmune encephalomyelitis, quality of life, and biomarkers.The scientific production related to MS treatment shows growth chronologically over the years. According to the findings of the analysis done to identify trending subjects, the key words studied in recent years were determined to be fingolimod, alemtuzumab, disease-modifying therapy, ocrelizumab, teriflunomide, rituximab, dimethyl fumarate, safety, biomarkers, COVID-19, oxidative stress, inflammation, vitamin D, relapsing multiple sclerosis, cost-effectiveness, cladribine tablets, and medication adherence. Western countries, especially European countries, the USA, and Canada lead the way in research and scientific collaboration on the subject of MS treatment. These findings can contribute to a better understanding of this subject and can help provide new ideas for further studies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
太一完成签到 ,获得积分10
刚刚
陈磨磨磨完成签到,获得积分10
1秒前
奋斗的大白菜完成签到,获得积分10
1秒前
skmksd发布了新的文献求助10
2秒前
CarryLJR的应助被Welysium采纳,获得10
2秒前
赘婿的应助被yyyyy采纳,获得10
2秒前
LIIII完成签到,获得积分10
3秒前
3秒前
fancy完成签到 ,获得积分10
3秒前
雨霖铃完成签到 ,获得积分10
3秒前
虚幻向秋完成签到,获得积分10
3秒前
大鱼大鱼完成签到,获得积分10
3秒前
幽默的热狗完成签到,获得积分10
3秒前
Aimiko完成签到,获得积分10
4秒前
甜美的大船完成签到,获得积分10
4秒前
Afterlife34发布了新的文献求助10
5秒前
fighting完成签到 ,获得积分10
5秒前
6秒前
ttomatoooooo完成签到,获得积分10
6秒前
6秒前
科研通AI65的应助被ayang123采纳,获得10
6秒前
李西瓜完成签到 ,获得积分10
7秒前
xyh完成签到,获得积分10
8秒前
科研通AI6.2的应助被王亮采纳,获得10
8秒前
哎呀我去完成签到,获得积分10
8秒前
Mojito完成签到,获得积分10
8秒前
闪闪的乐松完成签到 ,获得积分10
8秒前
果称完成签到,获得积分10
9秒前
欧大大完成签到,获得积分10
9秒前
一自文又欠完成签到 ,获得积分10
9秒前
10秒前
顺利橘子完成签到 ,获得积分10
10秒前
Yuson_L完成签到,获得积分10
10秒前
11秒前
franklin完成签到,获得积分10
11秒前
小蘑菇的应助被陈磨磨磨采纳,获得10
11秒前
温柔的依白完成签到,获得积分10
11秒前
11秒前
11秒前
GAO完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180189
求助须知:如何正确求助?哪些是违规求助? 9570320
关于积分的说明 21810161
捐赠科研通 7776320
什么是DOI,文献DOI怎么找? 3433267
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039